ATYR
aTyr Pharma, Inc.
0.305$
-9.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.8% | +3.6% | -20.8% | +4.6% | +83.1% | -7.3% | +3.0% | +30.0% | +61.7% | -43.8% | +0.8% | |
| – | +171.1% | – | – | – | – | -17.8% | +10.2% | +33.5% | +20.7% | +15.0% | +67.2% | |
| – | – | -141.3% | – | – | – | -1,197.6% | – | – | – | -146.1% | – | |
| – | +166.7% | -9.6% | +118.7% | -54.7% | -86.7% | +155.7% | -5.0% | +754.7% | +156.9% | -98.5% | +18.5% | |
| – | +3,105.4% | – | -182.4% | – | -86.8% | +40.1% | -1,427.0% | – | -142.6% | – | -129.3% | |
| – | – | – | – | – | – | – | – | – | +497.0% | +26.1% | +8.5% | |
| – | +5,788.4% | -96.8% | +1,022.1% | -108.0% | – | +1,108.3% | +581.6% | -95.0% | +1,115.0% | -39.8% | +65.6% | |
| – | – | -137.4% | – | – | -835.0% | – | -288.8% | – | +19.2% | -193.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.